Document Detail


Heart failure determines the myocardial inflammatory response to injury.
MedLine Citation:
PMID:  23143795     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
AIMS: Systemic complications after cardiac surgery are common in heart failure patients. However, the pathophysiological mechanisms, such as a different local inflammatory response of failing hearts, remain in question. This study examines whether failing hearts respond differently to cardioplegic arrest and reperfusion compared with non-failing hearts (controls). METHODS AND RESULTS: The inflammatory response was evaluated in samples collected simultaneously from the radial artery and coronary sinus, and myocardial tissue in 62 patients undergoing cardiac surgery. No myocardial release of inflammatory mediators was observed upon reperfusion in controls (n = 19). In contrast, in patients with heart failure, reperfusion was characterized by a myocardial release of several cytokines. Myocardial interleukin-6 was 115% increased in non-ischaemic heart failure (n = 18, P = 0.002) as compared with a 117% increase in patients with ischaemic heart failure (n = 25, P = 0.01). Furthermore, a myocardial release of monocyte chemoattractant protein-1 was observed in both patient groups: a 109% (P = 0.001) and 114% (P = 0.01) increase in patients with non-ischaemic heart failure and ischaemic heart failure, respectively. Post-operative myocardial damage, expression of inflammatory mediators, and p65-nuclear factor-κB activity were similar in all patient groups. Inflammatory cell content was increased in early ischaemic myocardial tissue in both heart failure groups compared with controls. CONCLUSION: Heart failure patients show a clear myocardial inflammatory response upon reperfusion, probably explained by degranulation of infiltrated inflammatory cells. Results in controls indicate that they better withstand cardioplegic arrest and reperfusion without an explicit myocardial inflammatory response.
Authors:
Kirsten A Kortekaas; Jan H Lindeman; Michel I Versteegh; Els van Beelen; Robert Kleemann; Robert J Klautz
Related Documents :
16501285 - The distal protection during primary percutaneous coronary intervention alleviates the ...
24252065 - Seeing what's happening on the inside: patients' views of the value of diagnostic cardi...
24080085 - Humoral control of cardiac remodelling in fish: role of angiotensin ii.
23682845 - Micro-structurally detailed model of a therapeutic hydrogel injectate in a rat biventri...
6824105 - Effect of cervical vagal stimulation on chicken heart rate and atrioventricular conduct...
3397195 - R wave amplitude changes during stress testing in ischemic patients with normal epicard...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-9
Journal Detail:
Title:  European journal of heart failure     Volume:  -     ISSN:  1879-0844     ISO Abbreviation:  Eur. J. Heart Fail.     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-12     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100887595     Medline TA:  Eur J Heart Fail     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Cardiothoracic Surgery, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Relationship of circulating matrix biomarkers to myocardial matrix metabolism in advanced heart fail...
Next Document:  Updated meta-analysis on antithrombotic therapy in patients with heart failure and sinus rhythm.